01 16Sumitomo Pharma Canada, Inc.
02 4Sunovion Pharmaceuticals Canada Inc.
01 42180301
02 42607427
03 42674303
04 42703313
05 42847235
01 20ESLICARBAZEPINE ACETATE
01 20TABLET
01 42016-07-02
02 42025-05-06
03 42028-01-14
04 42028-10-24
05 42032-08-24
Patent Expiration Date : 2016-07-02
Date Granted : 2004-02-10
Brand Name : APTIOM
Patent Number : 2180301
Filing Date : 1996-07-02
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2016-07-02
Date Granted : 2004-02-10
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2016-07-02
Date Granted : 2004-02-10
Brand Name : APTIOM
Patent Number : 2180301
Filing Date : 1996-07-02
Strength per Unit : 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2016-07-02
Date Granted : 2004-02-10
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2016-07-02
Date Granted : 2004-02-10
Brand Name : APTIOM
Patent Number : 2180301
Filing Date : 1996-07-02
Strength per Unit : 600 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2016-07-02
Date Granted : 2004-02-10
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2016-07-02
Date Granted : 2004-02-10
Brand Name : APTIOM
Patent Number : 2180301
Filing Date : 1996-07-02
Strength per Unit : 800 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2016-07-02
Date Granted : 2004-02-10
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2025-05-06
Date Granted : 2015-11-24
Brand Name : APTIOM
Patent Number : 2607427
Filing Date : 2005-05-06
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-05-06
Date Granted : 2015-11-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-01-14
Date Granted : 2017-02-28
Brand Name : APTIOM
Patent Number : 2674303
Filing Date : 2008-01-14
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-01-14
Date Granted : 2017-02-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-10-24
Date Granted : 2017-03-07
Brand Name : APTIOM
Patent Number : 2703313
Filing Date : 2008-10-24
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-10-24
Date Granted : 2017-03-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2032-08-24
Date Granted : 2020-07-07
Brand Name : APTIOM
Patent Number : 2847235
Filing Date : 2012-08-24
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2032-08-24
Date Granted : 2020-07-07
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2025-05-06
Date Granted : 2015-11-24
Brand Name : APTIOM
Patent Number : 2607427
Filing Date : 2005-05-06
Strength per Unit : 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2025-05-06
Date Granted : 2015-11-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-01-14
Date Granted : 2017-02-28
Brand Name : APTIOM
Patent Number : 2674303
Filing Date : 2008-01-14
Strength per Unit : 400 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-01-14
Date Granted : 2017-02-28
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
